Oppenheimer Asset Management Inc. Takeda Pharmaceutical CO LTD Transaction History
Oppenheimer Asset Management Inc.
- $7.78 Billion
- Q1 2025
A detailed history of Oppenheimer Asset Management Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 55,466 shares of TAK stock, worth $754,337. This represents 0.01% of its overall portfolio holdings.
Number of Shares
55,466
Previous 59,051
6.07%
Holding current value
$754,337
Previous $781,000
5.51%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding TAK
# of Institutions
373Shares Held
67.5MCall Options Held
1.72MPut Options Held
186K-
Capital Research Global Investors Los Angeles, CA13.2MShares$180 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.7MShares$77.6 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY5.32MShares$72.4 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.5MShares$47.7 Million0.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.43MShares$46.7 Million0.1% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $42.3B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...